Regulatory Escalation in Pharma Sector: China Imposes First Executive Sanctions in a Cartel Case

On May 9, 2025, the Tianjin Municipal Administration for Market Regulation (“Tianjin AMR”) announced administrative penalties against four manufacturers of dexamethasone sodium phosphate (“DSP”) active pharmaceutical ingredients (“APIs”) for engaging in a horizontal monopoly agreement….
By: Dacheng